Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular CarcinomaRiad Salem, Robert J. Lewandowski, Al B. Benson et al.|Gastroenterology|2016Cited by 686
Radiation Segmentectomy: Potential Curative Therapy for Early Hepatocellular CarcinomaRobert J. Lewandowski, Riad Salem, Ahmed Gabr et al.|Radiology|2018Cited by 250
Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000‐patient 15‐year experienceRiad Salem, Robert J. Lewandowski, Ahmed Gabr et al.|Hepatology|2017Cited by 235
Outcomes of Surgical Resection after Radioembolization for Hepatocellular CarcinomaAhmed Gabr, Riad Salem, Nadine Abouchaleh et al.|Journal of Vascular and Interventional Radiology|2018Cited by 97
Independent Analysis of Albumin-Bilirubin Grade in a 765-Patient Cohort Treated with Transarterial Locoregional Therapy for Hepatocellular CarcinomaRyan Hickey, Riad Salem, S. Mouli et al.|Journal of Vascular and Interventional Radiology|2016Cited by 72